[Patient memo. Advice for patients with psoriasis and using Soriatane].
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D017255:Acitretin / Q000009:adverse effects* / Q000627:therapeutic use*; D000328:Adult; D002784:Cholesterol / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D008099:Liver / Q000201:enzymology; D008297:Male; D008991:Monitoring, Physiologic; D011247:Pregnancy; D011565:Psoriasis / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood
D007641:Keratolytic Agents; D014280:Triglycerides; D002784:Cholesterol; D017255:Acitretin